Relationship between Postoperative Complications and Ratio of Amount of Wetting Solution to Ideal Body Weight in Liposuction Procedures.

Journal of personalized medicine 2024 Vol.14(5)

Aktas Yildirim S, Dogan L, Sarikaya ZT, Gucyetmez B, Demirtas Y, Toraman F

관련 도메인

Abstract

[BACKGROUND] The use of wetting solutions (WSs) during high-volume liposuction is standard; however, the optimal amount of WS and its components and their effect on postoperative complications are unclear. We evaluated the effect of a WS and its components, calculated according to ideal body weight (IBW), on postoperative complications.

[METHODS] High-volume liposuction with a WS containing 0.5 g of lidocaine and 0.5 mg of epinephrine in each liter was performed in 192 patients. Patients who received ≤90 mL/kg of WS were designated as group I and those who received >90 mL/kg of WS as group II. Postoperative complications and adverse events that occurred until discharge were recorded.

[RESULTS] The mean total amount of epinephrine in the WS was significantly higher for group II (3.5 mg; range, 3.0-4.0 mg) than for group I (2.0 mg; range, 1.8-2.5 mg; < 0.001), as was the mean total amount of lidocaine (3.5 g [range, 3.5-4.3 g] vs. 2.0 g [range, 1.8-2.5 g], respectively; < 0.001). No major cardiac or pulmonary complications occurred in either group. Administration of >90 mL/kg of WS increased the median risk of postoperative nausea 5.3-fold (range, 1.8- to 15.6-fold), that of hypertension 4.9-fold (range, 1.1- to 17.7-fold), and that of hypothermia 4.2-fold (range, 1.1- to 18.5-fold). The two groups had similar postoperative pain scores and blood transfusion rates.

[CONCLUSIONS] The risks of postoperative nausea, vomiting, hypothermia, and hypertension may increase in patients who receive >90 mL/kg of WS calculated according to IBW during high-volume liposuction.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 liposuction 지방흡입 dict 4
약물 lidocaine 리도카인 dict 2
약물 epinephrine 에피네프린 dict 2
해부 body scispacy 1
해부 cardiac scispacy 1
해부 pulmonary scispacy 1
해부 blood scispacy 1
약물 IBW → ideal body weight C0421272
Ideal Body Weight
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 WSs → wetting solutions scispacy 1
약물 [CONCLUSIONS] The scispacy 1
질환 cardiac or pulmonary complications scispacy 1
질환 nausea C0027497
Nausea
scispacy 1
질환 hypertension C0020538
Hypertensive disease
scispacy 1
질환 hypothermia C0020672
Hypothermia, natural
scispacy 1
질환 postoperative pain C0030201
Pain, Postoperative
scispacy 1
질환 postoperative nausea, vomiting C0520909
Postoperative Nausea and Vomiting
scispacy 1
기타 patients scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문